| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | $66.61B | $57.34B | $56.13B | $48.98B | $49.69B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | $70.83B | $77.00B | $61.86B | $18.05B | $8.14B |
| Tax Expense | $5.28B | $3.62B | $3.60B | $4.30B | $4.58B |
| Net Income | $20.37B | $16.24B | $14.87B | $15.81B | $16.05B |
| EPS (basic) | 14.1000 | 11.2700 | 10.5100 | 11.0800 | 11.0800 |
| EPS (diluted) | 14.0700 | 11.2500 | 10.5000 | 11.0600 | 11.0600 |
| Shares (diluted) | $1.41B | $1.41B | $1.39B | $1.41B | $1.43B |